ClearPoint Neuro, Inc. (CLPT) - Utang marang Ekuitas

CLPT (ClearPoint) - tandha merek perusahaan

Risks of prolonged procurement approvals and potential shifts in testing by gene delivery partners are weighing on ClearPoint Neuro, Inc. (CLPT), although liquidity is easing the pressure. ClearPoint Neuro, Inc. (CLPT) generates revenue through the implementation of navigation systems that lock clinics into its services and consumables. This chart of the asset's market value on GURU.Markets demonstrates a coefficient of 5.82, complementing the profile of the developer of AI platforms for precision neurosurgery.

ClearPoint Neuro Inc. - Utang marang Modal CLPT (periode 04.07.2022 - 28.10.2026)
Barang unggulan ClearPoint Neuro

The total debt-to-equity ratio measures the proportion of borrowed funds in the asset financing structure relative to equity. This metric allows an investor to assess the financial stability and the degree of the issuer's dependence on external creditors. The trend of total debt relative to equity reveals risks of over-leverage or the underutilization of leverage. For ClearPoint Neuro, Inc. (CLPT), the balance of borrowings is critical when scaling MRI navigation and implementing new FDA-approved technologies. An optimal level of debt will ensure expansion in the gene therapy segment without threatening solvency.

Pesaing utama

BSX: Utang marang Ekuitas|Koefisien Total Utang marang Modal EW|RMD - Utang marang Ekuitas|Utang Agregat marang Ekuitas Insulet Inc. (PODD)|ZBH: Total Utang marang Modal|Utang marang Modal coopercos.com COO|ALGN: Total Utang marang Modal|GMED - Rasio Total Utang marang Ekuitas|TransMedics - Total Utang marang Modal|Alphatec Corp (ATEC) - Koefisien Total Utang marang Modal|AORT (Artivion, Inc.) - Total Utang marang Modal|Total Utang marang Modal ENOV|Utang marang Ekuitas Integra LifeSciences Holdings Corporation (IART)|Utang marang Ekuitas Establishment Labs Corp (ESTA)|Total Utang marang Modal BBNX|IRMD - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas Embecta Corp.|TNDM - Utang Agregat marang Ekuitas|Total Utang marang Modal AXGN|SI-BONE Inc (SIBN) - Utang marang Modal|Total Utang marang Modal Orthofix International (OFIX)|Rasio Utang marang Ekuitas Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TMCI (treace.com)|Strata Critical Medical - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Carlsmed, Inc. CARL|RXST (RxSight Corp) - Total Utang marang Modal|STXS - Utang marang Modal|Total Utang marang Modal Neuronetics, Inc.|sightsciences.com (SGHT) - Rasio Utang marang Ekuitas|OBIO: Total Utang marang Modal|Koefisien Total Utang marang Modal Anika|Total Utang marang Modal NSPR (InspireMD Corp)|Rasio Total Utang marang Ekuitas zhjmedical.com (ZJYL)|Total Utang marang Modal VANI (Vivani Medical)|Xtant Medical Holdings, Inc. - Total Utang marang Modal|NMTC - Utang marang Ekuitas|Modular Medical (MODD) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Myomo, Inc MYO|Envoy Medical Inc (COCH) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal VVOS (Vivos Therapeutics)|Utang marang Modal NVNO|SINT: Utang marang Ekuitas|Rasio Utang marang Modal Tenon Medical Inc. TNON|Rasio Total Utang marang Ekuitas LFWD (ReWalk Robotics Ltd)|Total Utang marang Modal Autonomix Medical Inc. AMIX|Total Utang marang Modal IVF (INVO Fertility Inc)|BBLG: Koefisien Total Utang marang Modal|Utang marang Ekuitas Axonics (AXNX)|BIOL (BIOLASE Inc.) - Utang Agregat marang Ekuitas|Utang marang Ekuitas DYNT|Rasio Total Utang marang Ekuitas Paragon 28 Corp|INVO Bioscience, Inc. - Total Utang marang Modal